Clinical trial
Biorest Liposomal Alendronate Administration for Diabetic Patients Undergoing Drug-Eluting Stent Percutaneous Coronary Intervention
NCT02645799 is registered in ClinicalTrials.gov with BIOrest Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biorest Liposomal Alendronate Administration for Diabetic Patients Undergoing Drug-Eluting Stent Percutaneous Coronary Intervention
- Lead sponsor
- BIOrest Ltd.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- November 30, 2018
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.